GL1X · GenesisL1 explorer

MolNFT v1 · #90661 · protein

Discovery of small molecules that bind to K-RAS and inhibit sos- mediated activation

4EPY · GTPase KRAS: “Discovery of small molecules that bind to K-RAS and inhibit sos- mediated activation”. X-ray diffraction, 3 ligands (GDP, 0QY, MG), 1 pocket (best druggability 0.54). MolNFT v1 #90661 on GenesisL1: 3D structure…

PDB
4EPY
Type
protein
Length
170 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
EC
3.6.5.2
UniProt
P01116
Ligands
GDP, 0QY, MG
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRAS (EC 3.6.5.2)protein17038% helix, 24% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • 0QY · N-[2-(1H-indol-3-ylmethyl)-1H-benzimidazol-5-yl]-L-prolinamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11950.540.7939GDP, MG

Compared structures

  • 4EPY · Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activation · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.